Okawa S, Tomida S, Kuribayashi T, Nishimura J, et al. Colony-stimulating factor-1 receptor inhibitor augments osimertinib-induced anti-tumor immunity via suppression of macrophages in lung cancer harboring EGFR mutation. Mol Cancer Ther 2025 May 29. doi: 10.1158/1535-7163.MCT-25-0002.
PMID: 40439218